<DOC>
	<DOCNO>NCT00272064</DOCNO>
	<brief_summary>- The primary objective present study verify superiority Telecare program vs. standard SMBG program term mean HbA1c value ( - 0,5 % ) end-point . - The secondary objective study assessment : total daily dose insulin , change glycaemic lipid profile , frequency hypoglycaemia , change weight , health-related quality life , cost-effectiveness Telecare program vs. common ambulatory program ; general safety ( adverse event profile , routine laboratory parameter ) .</brief_summary>
	<brief_title>ELEONOR STUDY : Insulin Glulisine Type 2 Diabetes Mellitus .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Inclusion criterion : Diagnosis type 2 Diabetes Mellitus Patients treat combined oral antidiabetic drug ( fix combination simultaneous administration ) metformin monotherapy maximal dos least 3 month Patients BMI &gt; 25 Kg/m2 ; Patients HbA1c ≥ 7.5 % ≤ 11 % Female patient must menopausal , surgically sterile , use effective contraceptive measure ; Female childbearing potential must use effective contraceptive measure least 1 month prior entry study continue use contraceptive method overall study period . Exclusion criterion : Patients diagnose type 1 insulin dependent Diabetes Mellitus ; History two severe hypoglycaemic episode within past 3 month history unawareness hypoglycaemia ; Active proliferative diabetic retinopathy , define application focal panretinal photocoagulation vitrectomy , 6 month prior visit 1 , unstable ( rapidly progress ) retinopathy may require surgical treatment ( include laser photocoagulation ) ; Impaired renal function Impaired liver function History hypersensitivity insulin insulin analogues excipients Insulin glulisine Insulin glargine formulation History hypersensitivity metformin ; Pregnant breastfeed woman , woman plan become pregnant study ; Failure use adequate contraception ( woman current reproductive potential ) ; Any clinically significant major organ system disease relevant cardiovascular , gastrointestinal , hepatic , neurological , endocrine , haematological major systemic disease infective disease ; History drug alcohol abuse within last 2 year current addiction substance abuse ; Night shift worker ; Receipt experimental drug use experimental device within 30 day prior study entry ; Mental condition render subject unable understand nature , scope , possible consequence study ; Treatment likelihood require treatment study period drug permit clinical study protocol ; Any disease condition include abuse illicit drug , prescription medicine alcohol opinion investigator sponsor may interfere completion study ; Subject unlikely comply protocol , e.g. , uncooperative attitude , inability return followup visit , unlikelihood complete study procedure ; Subject investigator sub investigator , research assistant , pharmacist , study coordinator , staff relative thereof directly involve conduct protocol ; Previous enrolment present study . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>